(Q36456976)

14 August 2017

Projected future increase in aging hepatitis C virus-infected liver transplant candidates: a potential effect of hepatocellular carcinoma (English)

1 reference

14 August 2017

1 reference

1 reference

4

John Inadomi

1 reference

14 August 2017

9

John P Roberts

1 reference

14 August 2017

6

Jennifer L Dodge

1 reference

14 August 2017

3

Norah A Terrault

1 reference

14 August 2017

Scott W Biggins

1

1 reference

14 August 2017

Kiran M Bambha

2

1 reference

14 August 2017

Stephen Shiboski

5

1 reference

14 August 2017

Jane Gralla

7

1 reference

14 August 2017

Hugo R Rosen

8

1 reference

14 August 2017

1 December 2012

1 reference

14 August 2017

Liver Transplantation

1 reference

14 August 2017

18

1 reference

14 August 2017

12

1 reference

14 August 2017

1471-1478

1 reference

Centers for Disease Control and Prevention initiatives to prevent hepatitis C virus infection: a selective update

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3518670

Primary care-based interventions are associated with increases in hepatitis C virus testing for patients at risk

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3518670

The cost-effectiveness of birth-cohort screening for hepatitis C antibody in U.S. primary care settings

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3518670

Variation in organ quality between liver transplant centers

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3518670

Outcomes after liver transplant in patients aged 70 years or older compared with those younger than 60 years

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3518670

Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3518670

Liver resection for transplantable hepatocellular carcinoma: long-term survival and role of secondary liver transplantation

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3518670

An intention-to-treat analysis of liver transplantation for hepatocellular carcinoma using organ procurement transplant network data

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3518670

Trends in waiting list registration for liver transplantation for viral hepatitis in the United States

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3518670

Liver and intestine transplantation in the United States 1998-2007.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3518670

Surgical management of hepatocellular carcinoma: is the jury still out?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3518670

Increased all-cause, liver, and cardiac mortality among hepatitis C virus-seropositive blood donors

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3518670

The prevalence of hepatitis C virus infection in the United States, 1999 through 2002

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3518670

Hepatocellular carcinoma: recent trends in the United States

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3518670

Projecting future complications of chronic hepatitis C in the United States

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3518670

The past incidence of hepatitis C virus infection: implications for the future burden of chronic liver disease in the United States

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3518670

The prevalence of hepatitis C virus infection in the United States, 1988 through 1994

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3518670

Orthotopic liver transplant using allografts from geriatric population in the United States: is there any age limit?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3518670

Changing trends in hepatitis C-related mortality in the United States, 1995-2004.

28 June 2018

1 reference

Effect of aging on risk for hepatocellular carcinoma in chronic hepatitis C virus infection

21 January 2018

1 reference

Economic model of a birth cohort screening program for hepatitis C virus

21 January 2018

1 reference

Differential effects of donor age in liver transplant recipients infected with hepatitis B, hepatitis C and without viral hepatitis.

21 January 2018

1 reference

Liver transplantation in the United States, 1999-2008.

21 January 2018

1 reference

Analysis of liver transplant outcomes for United Network for Organ Sharing recipients 60 years old or older identifies multiple model for end-stage liver disease-independent prognostic factors

21 January 2018

1 reference

Arterial chemoembolization/embolization and early complications after hepatocellular carcinoma treatment: a safe standardized protocol in selected patients with Child class A and B cirrhosis.

21 January 2018

1 reference

Management of the single liver nodule in a cirrhotic patient: a decision analysis model.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3518670

Comparison of current US risk strategy to screen for hepatitis C virus with a hypothetical targeted birth cohort strategy

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3518670

Liver transplantation, liver resection, and transarterial chemoembolization for hepatocellular carcinoma in cirrhosis: which is the best oncological approach?

21 October 2018

1 reference

12 December 2020

Radiofrequency ablation of hepatocellular carcinoma: long-term results and prognostic factors in 235 Western patients with cirrhosis

1 reference

12 December 2020

Estimating future hepatitis C morbidity, mortality, and costs in the United States

1 reference

12 December 2020

The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update

1 reference

12 December 2020

Rising incidence of hepatocellular carcinoma in the United States

1 reference

12 December 2020

Identifiers

DOI

10.1002/LT.23551

1 reference

14 August 2017

1 reference

14 August 2017

PubMed publication ID

23008049

1 reference